Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.15 % |
3 Month Return | -4.11 % |
1 Year Return | -35.56 % |
Market Stats | |
Previous Close | ₹113.71 |
Open | ₹114.90 |
Volume | 53.36K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹489.55Cr |
P/E Ratio | -47.74 |
PEG Ratio | 4.33 |
Market Cap | ₹489.55 Cr |
P/B Ratio | 2.67 |
EPS | 0.07 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | -1.7 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹489.55 Cr | -6.76% | 0.60 | ₹29 Cr | ₹182 Cr | |
NA | ₹887.00 Cr | 264.92% | 0.91 | ₹55 Cr | ₹575 Cr | |
NA | ₹2,407.31 Cr | 159.02% | 0.62 | ₹43 Cr | ₹381 Cr | |
NA | ₹930.38 Cr | 681.88% | 0.65 | ₹23 Cr | ₹307 Cr | |
NA | ₹519.70 Cr | 31.31% | 0.56 | ₹13 Cr | ₹154 Cr |
Organisation | Valiant Laboratories Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Valiant Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 21.7 Cr → 24.84 Cr (in ₹), with an average increase of 12.6% per quarter
Retail Holding Up
Retail Investor have increased holdings from 23.17% to 25.06% in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 74.94% of holdings in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 1.89% to 0.00% in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, -0.51 Cr → -4.74 Cr (in ₹), with an average decrease of 829.4% per quarter
Price Dip
In the last 1 year, VALIANTLAB stock has moved down by -35.6%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 74.94% | 0.00 | |
Foreign Institutions | 0% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 25.06% | 8.17 | |
Others | 0% | 0.00 |
Valiant Laboratories Ltd in the last 5 years
Lowest (-147.86x)
July 11, 2024
Today (-47.74x)
December 24, 2024
Industry (56.56x)
December 24, 2024
Highest (413.29x)
April 10, 2024
Valiant Laboratories Ltd’s net profit fell -700% since last year same period to ₹-4.74Cr in the Q2 2024-2025. On a quarterly growth basis, Valiant Laboratories Ltd has generated -829.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Valiant Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Valiant Laboratories Ltd (VALIANTLAB) share price today is ₹112.67
Valiant Laboratories Ltd is listed on NSE
Valiant Laboratories Ltd is listed on BSE
PE Ratio of Valiant Laboratories Ltd is -47.74
PE ratio = Valiant Laboratories Ltd Market price per share / Valiant Laboratories Ltd Earnings per share
Today’s traded volume of Valiant Laboratories Ltd(VALIANTLAB) is 53.36K.
Today’s market capitalisation of Valiant Laboratories Ltd(VALIANTLAB) is ₹489.55Cr.
Valiant Laboratories Ltd(VALIANTLAB | Price |
---|---|
52 Week High | ₹214.95 |
52 Week Low | ₹100.2 |
Valiant Laboratories Ltd(VALIANTLAB) share price is ₹112.67. It is down -47.58% from its 52 Week High price of ₹214.95
Valiant Laboratories Ltd(VALIANTLAB) share price is ₹112.67. It is up 12.45% from its 52 Week Low price of ₹100.2
Valiant Laboratories Ltd(VALIANTLAB | Returns |
---|---|
1 Day Returns | -1.04% |
1 Month Returns | -0.15% |
3 Month Returns | -4.11% |
1 Year Returns | -35.56% |